Dr Suraj Munjal

Juvenile Macular Dystrophy

Juvenile Macular Dystrophy

Contact Us

    +91
    • India (भारत)+91
    • Afghanistan (‫افغانستان‬‎)+93
    • Åland Islands+358
    • Albania (Shqipëri)+355
    • Algeria (‫الجزائر‬‎)+213
    • American Samoa+1684
    • Andorra+376
    • Angola+244
    • Anguilla+1264
    • Antigua and Barbuda+1268
    • Argentina+54
    • Armenia (Հայաստան)+374
    • Aruba+297
    • Australia+61
    • Austria (Österreich)+43
    • Azerbaijan (Azərbaycan)+994
    • Bahamas+1242
    • Bahrain (‫البحرين‬‎)+973
    • Bangladesh (বাংলাদেশ)+880
    • Barbados+1246
    • Belarus (Беларусь)+375
    • Belgium (België)+32
    • Belize+501
    • Benin (Bénin)+229
    • Bermuda+1441
    • Bhutan (འབྲུག)+975
    • Bolivia+591
    • Bosnia and Herzegovina (Босна и Херцеговина)+387
    • Botswana+267
    • Brazil (Brasil)+55
    • British Indian Ocean Territory+246
    • British Virgin Islands+1284
    • Brunei+673
    • Bulgaria (България)+359
    • Burkina Faso+226
    • Burundi (Uburundi)+257
    • Cambodia (កម្ពុជា)+855
    • Cameroon (Cameroun)+237
    • Canada+1
    • Cape Verde (Kabu Verdi)+238
    • Caribbean Netherlands+599
    • Cayman Islands+1345
    • Central African Republic (République centrafricaine)+236
    • Chad (Tchad)+235
    • Chile+56
    • China (中国)+86
    • Christmas Island+61
    • Cocos (Keeling) Islands+61
    • Colombia+57
    • Comoros (‫جزر القمر‬‎)+269
    • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
    • Congo (Republic) (Congo-Brazzaville)+242
    • Cook Islands+682
    • Costa Rica+506
    • Côte d’Ivoire+225
    • Croatia (Hrvatska)+385
    • Cuba+53
    • Curaçao+599
    • Cyprus (Κύπρος)+357
    • Czech Republic (Česká republika)+420
    • Denmark (Danmark)+45
    • Djibouti+253
    • Dominica+1767
    • Dominican Republic (República Dominicana)+1
    • Ecuador+593
    • Egypt (‫مصر‬‎)+20
    • El Salvador+503
    • Equatorial Guinea (Guinea Ecuatorial)+240
    • Eritrea+291
    • Estonia (Eesti)+372
    • Ethiopia+251
    • Falkland Islands (Islas Malvinas)+500
    • Faroe Islands (Føroyar)+298
    • Fiji+679
    • Finland (Suomi)+358
    • France+33
    • French Guiana (Guyane française)+594
    • French Polynesia (Polynésie française)+689
    • Gabon+241
    • Gambia+220
    • Georgia (საქართველო)+995
    • Germany (Deutschland)+49
    • Ghana (Gaana)+233
    • Gibraltar+350
    • Greece (Ελλάδα)+30
    • Greenland (Kalaallit Nunaat)+299
    • Grenada+1473
    • Guadeloupe+590
    • Guam+1671
    • Guatemala+502
    • Guernsey+44
    • Guinea (Guinée)+224
    • Guinea-Bissau (Guiné Bissau)+245
    • Guyana+592
    • Haiti+509
    • Honduras+504
    • Hong Kong (香港)+852
    • Hungary (Magyarország)+36
    • Iceland (Ísland)+354
    • India (भारत)+91
    • Indonesia+62
    • Iran (‫ایران‬‎)+98
    • Iraq (‫العراق‬‎)+964
    • Ireland+353
    • Isle of Man+44
    • Israel (‫ישראל‬‎)+972
    • Italy (Italia)+39
    • Jamaica+1
    • Japan (日本)+81
    • Jersey+44
    • Jordan (‫الأردن‬‎)+962
    • Kazakhstan (Казахстан)+7
    • Kenya+254
    • Kiribati+686
    • Kuwait (‫الكويت‬‎)+965
    • Kyrgyzstan (Кыргызстан)+996
    • Laos (ລາວ)+856
    • Latvia (Latvija)+371
    • Lebanon (‫لبنان‬‎)+961
    • Lesotho+266
    • Liberia+231
    • Libya (‫ليبيا‬‎)+218
    • Liechtenstein+423
    • Lithuania (Lietuva)+370
    • Luxembourg+352
    • Macau (澳門)+853
    • Macedonia (FYROM) (Македонија)+389
    • Madagascar (Madagasikara)+261
    • Malawi+265
    • Malaysia+60
    • Maldives+960
    • Mali+223
    • Malta+356
    • Marshall Islands+692
    • Martinique+596
    • Mauritania (‫موريتانيا‬‎)+222
    • Mauritius (Moris)+230
    • Mayotte+262
    • Mexico (México)+52
    • Micronesia+691
    • Moldova (Republica Moldova)+373
    • Monaco+377
    • Mongolia (Монгол)+976
    • Montenegro (Crna Gora)+382
    • Montserrat+1664
    • Morocco (‫المغرب‬‎)+212
    • Mozambique (Moçambique)+258
    • Myanmar (Burma) (မြန်မာ)+95
    • Namibia (Namibië)+264
    • Nauru+674
    • Nepal (नेपाल)+977
    • Netherlands (Nederland)+31
    • New Caledonia (Nouvelle-Calédonie)+687
    • New Zealand+64
    • Nicaragua+505
    • Niger (Nijar)+227
    • Nigeria+234
    • Niue+683
    • Norfolk Island+672
    • North Korea (조선 민주주의 인민 공화국)+850
    • Northern Mariana Islands+1670
    • Norway (Norge)+47
    • Oman (‫عُمان‬‎)+968
    • Pakistan (‫پاکستان‬‎)+92
    • Palau+680
    • Palestine (‫فلسطين‬‎)+970
    • Panama (Panamá)+507
    • Papua New Guinea+675
    • Paraguay+595
    • Peru (Perú)+51
    • Philippines+63
    • Poland (Polska)+48
    • Portugal+351
    • Puerto Rico+1
    • Qatar (‫قطر‬‎)+974
    • Réunion (La Réunion)+262
    • Romania (România)+40
    • Russia (Россия)+7
    • Rwanda+250
    • Saint Barthélemy+590
    • Saint Helena+290
    • Saint Kitts and Nevis+1869
    • Saint Lucia+1758
    • Saint Martin (Saint-Martin (partie française))+590
    • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
    • Saint Vincent and the Grenadines+1784
    • Samoa+685
    • San Marino+378
    • São Tomé and Príncipe (São Tomé e Príncipe)+239
    • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
    • Senegal (Sénégal)+221
    • Serbia (Србија)+381
    • Seychelles+248
    • Sierra Leone+232
    • Singapore+65
    • Sint Maarten+1721
    • Slovakia (Slovensko)+421
    • Slovenia (Slovenija)+386
    • Solomon Islands+677
    • Somalia (Soomaaliya)+252
    • South Africa+27
    • South Korea (대한민국)+82
    • South Sudan (‫جنوب السودان‬‎)+211
    • Spain (España)+34
    • Sri Lanka (ශ්‍රී ලංකාව)+94
    • Sudan (‫السودان‬‎)+249
    • Suriname+597
    • Svalbard and Jan Mayen+47
    • Swaziland+268
    • Sweden (Sverige)+46
    • Switzerland (Schweiz)+41
    • Syria (‫سوريا‬‎)+963
    • Taiwan (台灣)+886
    • Tajikistan+992
    • Tanzania+255
    • Thailand (ไทย)+66
    • Timor-Leste+670
    • Togo+228
    • Tokelau+690
    • Tonga+676
    • Trinidad and Tobago+1868
    • Tunisia (‫تونس‬‎)+216
    • Turkey (Türkiye)+90
    • Turkmenistan+993
    • Turks and Caicos Islands+1649
    • Tuvalu+688
    • U.S. Virgin Islands+1340
    • Uganda+256
    • Ukraine (Україна)+380
    • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
    • United Kingdom+44
    • United States+1
    • Uruguay+598
    • Uzbekistan (Oʻzbekiston)+998
    • Vanuatu+678
    • Vatican City (Città del Vaticano)+39
    • Venezuela+58
    • Vietnam (Việt Nam)+84
    • Wallis and Futuna (Wallis-et-Futuna)+681
    • Western Sahara (‫الصحراء الغربية‬‎)+212
    • Yemen (‫اليمن‬‎)+967
    • Zambia+260
    • Zimbabwe+263


    Related Videos :

    Frequently Asked Questions (FAQ) :

    1. Can Juvenile Macular Dystrophy be cured?

    Currently, there is no cure for JMD. However, early diagnosis and appropriate treatment can help manage symptoms and slow the progression of the disease.

     

    Yes, JMD is caused by genetic mutations and is typically inherited from parents.

     

    Symptoms usually appear in childhood or adolescence, though the severity and rate of progression can vary.

     

    Juvenile Macular Dystrophy

    About Juvenile Macular Dystrophy (JMD)

    Juvenile Macular Dystrophy encompasses several hereditary eye conditions that result in the deterioration of the macula. While these conditions are rare, they significantly affect central vision, making tasks like reading and recognizing faces difficult for young patients. Despite being progressive, some treatment options can help slow down the disease’s effects.

    Causes of Juvenile Macular Dystrophy

    The main cause of Juvenile Macular Dystrophy is genetic mutations. These mutations affect the function of the retina and specifically the macula, which is responsible for central vision. If a parent carries the gene mutation, there is a chance of passing it on to the child, even if the parent does not experience vision issues.

    Some common genetic causes include:

    • Mutations in the ABCA4 gene: Linked to Stargardt disease.
    • Mutations in the BEST1 gene: Associated with Best’s disease.
    • Other gene mutations: Affecting retinal pigment and leading to macular degeneration.

    Types of Juvenile Macular Dystrophy

    There are several types of Juvenile Macular Dystrophy, each with its own unique set of characteristics:

    1. Stargardt Disease: The most common type of JMD, causing a progressive loss of central vision.
    2. Best’s Disease (Best Vitelliform Macular Dystrophy): Causes yellowish deposits in the macula and a gradual loss of vision.
    3. X-Linked Retinoschisis: Affects young males, leading to a splitting of the retina layers and central vision problems.
    4. Cone-Rod Dystrophy: Affects both the cone and rod cells, leading to color vision and night vision issues, along with central vision loss.

    Symptoms of Juvenile Macular Dystrophy

    The symptoms of JMD vary depending on the type, but common signs include:

    • Blurred central vision: Difficulty seeing fine details or reading.
    • Difficulty in recognizing faces: Vision problems with recognizing people from a distance.
    • Sensitivity to light (photophobia): Discomfort in bright environments.
    • Loss of color vision: Difficulty distinguishing between colors.
    • Distorted or wavy vision: Lines that appear curved or bent.

    These symptoms typically develop in childhood or adolescence and progressively worsen over time.

    Diagnosis of Juvenile Macular Dystrophy

    Dr. Suraj Munjal recommends a comprehensive eye exam to diagnose Juvenile Macular Dystrophy. This may include:

    • Visual Acuity Test: To measure clarity of vision.
    • Ophthalmoscopy: To examine the retina and macula for abnormalities.
    • Optical Coherence Tomography (OCT): A detailed imaging test to assess the layers of the retina.
    • Fundus Autofluorescence (FAF): To check for lipofuscin buildup, which is common in Stargardt disease.
    • Genetic Testing: To confirm the presence of mutations associated with JMD.

    Early diagnosis is crucial to managing symptoms and slowing the progression of the disease.

    Treatment for Juvenile Macular Dystrophy

    While there is currently no cure for Juvenile Macular Dystrophy, several treatment options can help manage symptoms and slow disease progression:

    1. Low Vision Aids: Devices like magnifiers, large-print materials, and special glasses can enhance remaining vision.
    2. Vitamin A Supplements: These may help in some cases, particularly for Stargardt disease, but should be taken under medical supervision.
    3. Gene Therapy: A promising area of research aimed at correcting genetic defects.
    4. Anti-VEGF Injections: These injections, typically used for age-related macular degeneration, can sometimes benefit patients with JMD by reducing abnormal blood vessel growth.
    5. Regular Monitoring: Frequent eye exams to track disease progression.

    Cost of Treatment and Stay in India

    India has become a popular destination for quality eye care at affordable costs. The cost of treatment for Juvenile Macular Dystrophy in India is considerably lower compared to Western countries, without compromising on quality. Dr. Suraj Munjal offers personalized care packages that include:

    • Consultation Fees: Approximately $50 – $100.
    • Diagnostic Tests: OCT, genetic testing, and other eye exams can range between $200 and $500.
    • Treatment Costs: Vary depending on the treatment plan but are generally between $500 to $2,000.
    ×